Before becoming Outset’s President and CEO, Leslie was the company’s COO and also served as an Executive-in-Residence at Warburg Pincus. Prior to Outset, she was Executive Vice President at Lutonix, a cardiovascular medical device company acquired by CR Bard. She began her medical device career at Guidant Corporation in new product global marketing. At Outset they’re changing dialysis with Tablo, a new hemodialysis system designed to put the patient before the machine and designed for simplicity. A system designed for flexibility.